Drug Trial Radar · NCT03545191
Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder
Last checked: Nov 19, 2026Latest source record: Mar 25, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
930
Actual
Start
Jun 4, 2018
Primary completion
Jan 25, 2020
Study completion Feb 25, 2020
Sponsor
- Lead sponsor
- Idorsia Pharmaceuticals Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 4, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to assess efficacy and safety of ACT-541468 (daridorexant) in adult and elderly subjects with insomnia disorder. Efficacy will be evaluated on objective and subjective sleep parameters.
Conditions
- Insomnia Disorder
Interventions
Daridorexant 25 mgDrug
Daridorexant will be administered as tablets, orally, once daily in the evening.
Daridorexant 50 mgDrug
Daridorexant will be administered as tablets, orally, once daily in the evening.
PlaceboOther
Matching placebo will be administered as tablets, orally, once daily in the evening.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to Month 1 in Wake After Sleep Onset (WASO) (Sleep Maintenance)Time frame: From baseline to Month 1 (i.e. for up to 1 month)
- Change From Baseline to Month 3 in Wake After Sleep Onset (WASO)Time frame: From baseline to Month 3 (i.e. for up to 3 months)
- Change From Baseline to Month 1 in Latency to Persistent Sleep (LPS) (Sleep Onset)Time frame: From baseline to Month 1 (i.e. for up to 1 month)
- Change From Baseline to Month 3 in Latency to Persistent Sleep (LPS)Time frame: From baseline to Month 3 (i.e. for up to 3 months)
Locations
81 sites in 10 countries. Site status is shown where the registry gives one.
Pinnacle Research Group, LLC
Anniston, Alabama
Pulmonary Associates of the Southeast/WCR
Birmingham, Alabama
Preferred Research Partners, Inc
Little Rock, Arkansas
Woodland Research Northwest
Rogers, Arkansas
Marvel Clinical Research
Huntington Beach, California
Long Beach Clinical Trials
Long Beach, California
Artemis Institute for Clinical Research
San Diego, California
PAB Clinical Research
Brandon, Florida
St. Francis Sleep Allergy and Lung Institute
Clearwater, Florida
Innovative Clinical Research, Inc.
Hialeah, Florida
Research Centers of America
Hollywood, Florida
Canvas Clinical Research, LLC
Lake Worth, Florida
BioMed Research Institute
Miami, Florida
Clinical Site Partners, LLC
Winter Park, Florida
LaPorte County Institute for Clinical Research
Michigan City, Indiana
Kentucky Research Group
Louisville, Kentucky
Helene Emsellem, MD
Chevy Chase, Maryland
Infinity Medical Research, Inc.
North Dartmouth, Massachusetts
Barrett Clinic
La Vista, Nebraska
Clinical Research Center of Nevada
Las Vegas, Nevada
Clinilabs NYC
New York, New York
Research Carolina of Huntersville
Huntersville, North Carolina
Coastal Carolina Healthcare
New Bern, North Carolina
CTI Clinical Research Center
Cincinnati, Ohio
Oregon Center for Clinical Investigations,Inc
Salem, Oregon
BTC of Lincoln
Lincoln, Rhode Island
Omega Medical Research
Warwick, Rhode Island
Bogan Sleep Consulting, LLC
Columbia, South Carolina
Coastal Carolina Research Center
Mt. Pleasant, South Carolina
Tri-State Mountain Neurology
Johnson City, Tennessee
Inquest Clinical Research
Baytown, Texas
Sleep Therapy & Research Center
San Antonio, Texas
Aspen Clinical Research
Orem, Utah
Pulmonary Associates of Richmond
Richmond, Virginia
Sleep Disorders Centers of the Mid-Atlantic
Vienna, Virginia
Swedish Medical Center
Seattle, Washington
Respiratory Clinical Trials
Adelaide, Australia
Genesis Sleep Care Queensland
Auchenflower, Australia
Melbourne Sleep Disorders Centre
East Melbourne, Australia
The Woolcock Institute of Medical Research
Glebe, Australia
Showing 40 of 81 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.